Combination therapy of percutaneous mitoxantrone injection, percutaneous ethanol injection, and transcatheter arterial embolization for intrahepatic hepatocellular carcinoma and adrenal metastasis
T. Kiba et al., Combination therapy of percutaneous mitoxantrone injection, percutaneous ethanol injection, and transcatheter arterial embolization for intrahepatic hepatocellular carcinoma and adrenal metastasis, HEP-GASTRO, 48(38), 2001, pp. 427-431
We treated a 63-year-old man who had recurrent large hepatocellular carcino
mas (>5cm in diameter) and left adrenal metastasis with the combination app
roach of percutaneous intratumoral chemotherapy with mitoxantronc, percutan
eous ethanol injection, and transcatheter arterial embolization. He receive
d repeated transcatheter arterial embolization and percutaneous ethanol inj
ection combination therapy for intrahepatic hepatocellular carcinomas, whic
h controlled his disease for 6 months from the first treatment. After that,
left adrenal metastasis was detected by biopsy specimen. Therefore, we rep
eated more transcatheter arterial embolization and percutaneous ethanol inj
ection to the liver and left adrenal gland, but this combination therapy co
uld not control the hepatocellular carcinomas in these organs. With the pat
ient's consent, he was treated with the combination approach of percutaneou
s intratumoral chemotherapy with mitoxantrone, percutaneous ethanol injecti
on, and transcatheter arterial embolization for hepatocellular carcinomas o
f the liver and left adrenal gland. After this combination therapy, we foll
owed-up the viable lesions by color Doppler ultrasonography and computed to
mography examination. However, we could not detect these viable lesions of
hepatocellular carcinomas in his body until one month before he died, When
the degree of hepatic failure worsened due to the natural course of cirrhos
is, this combination therapy was stopped 7 months before he died. He died o
f pulmonary tumor emboli from metastasis of inferior vena cava 24 months af
ter the combination therapy started. However, on autopsy there was almost n
o remaining hepatocellular carcinoma found in the main lesions of liver and
left adrenal gland. We suggest that a combination approach of percutaneous
intratumoral chemotherapy with mitoxantrone, percutaneous ethanol injectio
n, and transcatheter arterial embolization may be indicated in elderly case
s of intrahepatic large hepatocellular carcinoma and adrenal metastasis, wh
ich are not under control only by transcatheter arterial embolization and p
ercutaneous ethanol injection.